ZNTL
Zentalis Pharmaceuticals, Inc.Company with tickers: ZNTL
CIK
1725160
CUSIP
98943L107
Shares Outstanding
71,186,348
Website
https://www.zentalis.com
Investor Relations
https://ir.zentalis.com/overview/default.aspx
13F Activity (30d)
4 filings
3 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $9,976,000 | 10-K, filed 2026-03-26 | ||